CellMosaic, based in Worcester, MA, is a renowned biotechnology company specializing in the development and manufacturing of Antibody Drug Conjugate ADC Kits and AqT bioconjugates. Their wide range of products and services cater to bioconjugation drug development and manufacturing needs.
With a strong focus on advancing AqT technologies to tackle biocompatibility and toxicity challenges in bioconjugates and biopharmaceuticals, CellMosaic stands out as a leader in the rapidly growing ADC market. Under the leadership of Dr. Huang and Dr. Dey, the company has secured multiple patents, introduced innovative products, and gained recognition for their groundbreaking technologies.